Fig. 1From: A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cellsAmotL2 expression in invasive cancers. Immunohistochemical analysis of AmotL2 expression in human glioblastoma, neuroendocrine, prostate and breast cancer. Note the cytoplasmic vesicular staining in brown, characteristic of p60AmotL2 expression. Scale bar = 50 μmBack to article page